Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ALBO Albireo Pharma Inc

0.00 (0.0%)
Nov 29 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 0
Bid Price 44.10
Ask Price 44.33
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Albireo Pharma Inc ALBO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 44.15 19:00:00
Open Price Low Price High Price Close Price Prev Close
44.15 44.15
Trades Volume Avg Volume 52 Week Range
0 0 - 17.78 - 45.23
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 44.15 USD

Albireo Pharma Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 913.96M - - - -2,420.78
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Albireo Pharma News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No ALBO Message Board. Create One! See More Posts on ALBO Message Board See More Message Board Posts

Historical ALBO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months0.
6 Months0.
1 Year21.7745.2317.7841.31503,39122.38102.8%
3 Years36.9745.2316.0230.38276,9587.1819.42%
5 Years25.8352.9011.2630.31202,13118.3270.93%

Albireo Pharma Description

Albireo Pharma Inc is a commercial-stage biopharmaceutical company. It focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders. The Company's product pipeline includes Bylvay, which is approved in the United States and Europe; elobixibat, which is approved in Japan for the treatment of chronic constipation; A3907, its Phase 1 lead candidate for the treatment of adult liver diseases; and A2342, it's a lead preclinical candidate for the treatment of adult viral and liver diseases.

Your Recent History

Delayed Upgrade Clock